Papers
62
Total Citations
2,104
H-Index
24
About
Chang Moo Kang is a pioneering surgeon whose work has fundamentally advanced minimally invasive and robotic approaches to complex abdominal oncological procedures. Based at Yonsei University, Kang has established himself as a leading figure in hepatopancreatic and colorectal surgery, with a particular focus on robotic-assisted and laparoscopic techniques for cancers of the pancreas, liver, and rectum. Kang's most influential contributions include early landmark studies demonstrating the clinical viability of robotic surgery across multiple organ systems. His 2008 pilot randomized trial on robotic mesorectal excision for rectal cancer (303 citations) and his comparative analysis of robotic versus conventional laparoscopic pancreatectomy (222 citations) helped establish the evidence base for adopting robotic platforms in technically demanding oncological resections. His series on robotic liver resection and spleen-preserving distal pancreatectomy further expanded the frontier of what minimally invasive surgery could achieve with acceptable safety profiles. Notably, Kang's development and refinement of the radical antegrade modular pancreatosplenectomy (RAMPS) procedure for left-sided pancreatic ductal adenocarcinoma represents a significant oncological advancement, emphasizing both surgical precision and long-term survival outcomes. With over 1,300 cumulative citations, his body of work continues to shape surgical training and practice internationally.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3Robotic liver resection: technique and results of 30 consecutive procedures154 citations · 2012
- 4
- 5
- 6
- 7
- 8Laparoscopic major liver resection in Korea: a multicenter study69 citations · 2012
- 9
- 10